A is intended to test for osteoporosis, an infection which happens when the bones turn out to be weak and thin. A great many people nowadays go for a bone thickness scan from a machine utilizing a technology known as dual-energy x-ray absorptiometry. The device captures a photo of the bones in the hip, spine, wrist and overall body and ascertains their density. In the event that a DXA device isn’t accessible, bone density scans may likewise be completed with dual photon absorptiometry (determining the hip, spine and overall body) along with quantitative computed tomography scans (determining the hips and spine). The DXA scanner is generally found in huge medical centers and medical groups.
The purpose of a bone density filter is to measure the thickness of a person’s bones and conclude the danger of fracture. The worldwide market for bone densitometer devices was projected to surpass US$ 260 Million through 2016. The overall market is considered to expand more than US$ 375 Million by 2026 end, recording a 3.5% CAGR throughout the assessment period of 2016–2026.
Based on the product type and technology, the overall market is categorized into quantitative ultrasound (QUS), absorptiometry (pDXA), peripheral dual energy X-Ray, dual energy X-Ray absorptiometry (DXA) and others.
Based on the end user, the worldwide market is categorized into diagnostic centers, orthopedic clinics and hospitals. The hospital’s category is expected to remain highly lucrative category in the worldwide market for bone densitometer devices. The diagnostic center’s category is considered to exhibit robust growth as a result of growing number of diagnostic centers for measuring bone health globally. The orthopedic clinic’s category will be having considerably fewer installations of the bone densitometer devices because of rising prices of the instruments.
The worldwide market for bone densitometer devices is studied across the seven regions namely, Middle East & Africa, Asia-Pacific excluding Japan, Japan as a separate region, Latin America, North America, Eastern Europe and Western Europe. The APEJ and North America markets offer huge growth opportunities for the manufacturers of bone densitometer devices because of a huge patient population along with huge demand for the devices in these regions. North America is the highest growing market and is estimated to account for a value over US$ 150 Million along with a revenue share surpassing 50% through 2026 end, recording a 3.6% CAGR during the projection period. APEJ is estimated to grow at a CAGR of 4.2%, to gain around 16% share in the worldwide market by the end of the forecast period.
Key Market Players
Some of the worldwide bone densitometer devices companies operating in the market include: Hologic Inc., GE Healthcare, Beammed Ltd., Osteosys Co. Ltd, Swissray International Inc., Diagnostic medical System SA
Queries regarding these research findings can be addressed to Future Market Insights’ analysts at firstname.lastname@example.org